Structural Characterization of the Human Proteome

Total Page:16

File Type:pdf, Size:1020Kb

Structural Characterization of the Human Proteome Article Structural Characterization of the Human Proteome Arne Mu¨ller,1 Robert M. MacCallum,1,4 and Michael J.E. Sternberg1,2,3 1Biomolecular Modelling Laboratory, Cancer Research UK, London, United Kingdom; 2Department of Biological Sciences, Structural Bioinformatics Group, Imperial College of Science, Technology and Medicine, South Kensington, London, United Kingdom This paper reports an analysis of the encoded proteins (the proteome) of the genomes of human, fly, worm, yeast, and representatives of bacteria and archaea in terms of the three-dimensional structures of their globular domains together with a general sequence-based study. We show that 39% of the human proteome can be assigned to known structures. We estimate that for 77% of the proteome, there is some functional annotation, but only 26% of the proteome can be assigned to standard sequence motifs that characterize function. Of the human protein sequences, 13% are transmembrane proteins, but only 3% of the residues in the proteome form membrane-spanning regions. There are substantial differences in the composition of globular domains of transmembrane proteins between the proteomes we have analyzed. Commonly occurring structural superfamilies are identified within the proteome. The frequencies of these superfamilies enable us to estimate that 98% of the human proteome evolved by domain duplication, with four of the 10 most duplicated superfamilies specific for multicellular organisms. The zinc-finger superfamily is massively duplicated in human compared to fly and worm, and occurrence of domains in repeats is more common in metazoa than in single cellular organisms. Structural superfamilies over- and underrepresented in human disease genes have been identified. Data and results can be downloaded and analyzed via web-based applications at http://www.sbg. bio.ic.ac.uk. [Supplemental material is available online at http://www.genome.org.] The interpretation and exploitation of the wealth of biologi- maintaining a high coverage. In the absence of a match to cal knowledge that can be derived from the human genome these characterized motifs/domains, suggestion for a func- (Lander et al. 2001; Venter et al. 2001)requires an analysis of tional annotation comes from a homology to a previously the three-dimensional structures and the functions of the en- functionally annotated sequence. However, transfer of func- coded proteins (the proteome). Comparison of this analysis tion via an identified homology is problematic and the extent with those of other eukaryotic and prokaryotic proteomes will of the difficulty has been recently quantified (e.g., Devos and identify which structural and functional features are common Valencia 2000; Wilson et al. 2000; Todd et al. 2001). Below and which confer species specificity. In this paper, we present 30% pair-wise sequence identity, two proteins often may have an integrated analysis of the proteomes of human and 13 quite different functions even if their structures are similar. other species considering the folds of globular domains, the Because of this problem, global bioinformatics analyses of ge- presence of transmembrane proteins, and the extent to which nomes generally do not use functional transfer from distant the proteomes can be functionally annotated. This integrated homologies for annotation. However, specific analyses by hu- approach enables us to consider the relationship between man experts still extensively employ this strategy, particularly these different aspects of annotation and thereby enhance as any suggestion of function can be refined from additional previous analyses of the human and other proteomes (e.g., information or from further experiments. Koonin et al. 2000; Frishman et al. 2001; Iliopoulos et al. A powerful source of additional information is available 2001), including the seminal papers reporting the human ge- when the three-dimensional coordinates of the protein are nome sequence (Lander et al. 2001; Venter et al. 2001). known. The structure often provides information about the A widely used first step in a bioinformatics-based func- residues forming ligand-binding regions that can assist in tional annotation is to identify known sequence motifs and evaluating the function and specificity of a protein. For ex- domains from manually curated databases such as PFAM/ ample, recently we have shown that spatial clustering of in- INTERPRO (Bateman et al. 2000)and PANTHER (Venter et al. variant residues can assist in assessing the validity of function 2001). This strategy was used in the original analyses of the transfer in this twilight zone (Aloy et al. 2001). At higher human proteome (Lander et al. 2001; Venter et al. 2001). levels of identity, knowledge of structure can assist in analyz- These annotations tend to be reliable, as these libraries have ing ligand specificity and the effect of point mutations. been carefully constructed to avoid false positives whilst A valuable tool in exploiting three-dimensional informa- tion is the databases of protein structure in which domains with similar three-dimensional architecture are grouped to- 3Present address: Stockholm Bioinformatics Center, Department gether. Here, we use the structural classification of proteins of Biochemistry and Biophysics, Stockholm University, S-106 91 (SCOP)(Conte et al. 2000).In SCOP, protein domains of Stockholm, Sweden. known structure that are likely to be homologs are grouped by 4 Corresponding author. an expert into a common superfamily based on their struc- E MAIL [email protected]; FAX +44-(0)20-7594-5264. Article and publication are at http://www.genome.org/cgi/doi/10.1101/ tural similarity together with functional and evolutionary gr.221202. considerations. SCOP is widely regarded as an accurate assess- 12:1625–1641 ©2002 by Cold Spring Harbor Laboratory Press ISSN 1088-9051/02 $5.00; www.genome.org Genome Research 1625 www.genome.org Müller et al. ment of which domains are homologs. However, SCOP re- mains subjective and one cannot exclude the possibility that two domains placed within the same superfamily only share a common fold as a result of convergent evolution and there- fore are not homologous. The above considerations have led us to focus our analy- sis on the following three objectives: (i)to estimate the extent to which the known proteomes can be annotated in terms of structure and function and how reliable we consider these annotations to be; (ii)to place the occurrence of particular SCOP structural superfamilies in terms of their biological and species-specific contexts; and (iii)to derive evolutionary in- sights from frequency-based analysis of homologous SCOP domains. Strategy for Structural and Functional Annotations Protein sequences from the human genome and from 13 other species were analyzed (for details, see Methods). The main strategy was to use the sensitive protein sequence simi- larity search program PSI-BLAST (Altschul et al. 1997)to scan each protein sequence against a database composed of a nonredundant set of sequences augmented by the sequences of each SCOP domain and, to ensure up-to-date coverage, each protein entry of the PDB (Berman et al. 2000). Functional annotation was considered as sequence matches to the PFAM domain library (excluding families of unknown function), which is now part of the more general INTERPRO database. In the absence of a match to these char- acterized motifs/domains, we need to evaluate functional an- notation via transfer from homology. To represent this ap- proach computationally, we simply considered a functional annotation if a homolog contains some textual description of function (see legend to Fig. 1A). Thus, the total of the pro- teome that can be functionally annotated is the sections that are assigned to a PFAM domain or, if no assignment to PFAM, the sections that are homologous to a protein with a text functional description. Status of Structural and Functional Annotations Figure 1A shows the structural annotation status of the pro- teomes expressed as the fraction of the total residues in each proteome. We use the residue fraction to include situations when only part of a protein sequence is annotated, as one cannot quantify this as a fraction of domains because one does not know the number of domains in unannotated re- gions. Thirty-nine percent of the human proteome can be structurally annotated from either having a known protein Figure 1 Structural and functional annotation of the proteomes. (A) structure or via a PSI-BLAST detectable homology to a known Coverage for each species is reported as the fraction of the residues in the proteome that are annotated. This allows for partial coverage of structure. This percentage is higher than that for yeast, fly, any sequence. Structural annotation is a homology to a known struc- and worm and is comparable to the coverage of many bacteria ture. Functional annotation is when there is no structural annotation and archaea. A further 38% of the human genome falls into but there is a homology to an entry from SwissProt or PIR that has a the category of functional annotation without structure. Be- description other than those that contain any of the following words: cause nearly every protein structure has some functional an- “hypothetical”, “probable”, “putative”, “predicted”. Any homology notation, the total functional annotation of the human pro- denotes a sequence similarity to a structurally or functionally unan- notated protein, such as one described as hypothetical. Nonglobular teome is 77%. The remainder are (i)either homologous to denotes remaining sequence regions that were predicted as trans- another protein of unknown function, or (ii)orphan regions membrane, signal peptide, coiled-coils, or low-complexity. Remain- without any detectable homology, or (iii)an unannotated, ing residues are classified as orphans. (B) Structural and functional nonglobular region (a region of low complexity, coiled-coil, annotations that cover the entire protein sequence. For structural or a transmembrane segment). annotation, we required that >95% of the sequence was structurally We also consider how many protein sequences can be annotated and there was no unannotated segment of >30 residues.
Recommended publications
  • Primepcr™Assay Validation Report
    PrimePCR™Assay Validation Report Gene Information Gene Name mature T-cell proliferation 1 Gene Symbol MTCP1 Organism Human Gene Summary This gene was identified by involvement in some t(X;14) translocations associated with mature T-cell proliferations. This region has a complex gene structure with a common promoter and 5' exon spliced to two different sets of 3' exons that encode two different proteins. This gene represents the upstream 13 kDa protein that is a member of the TCL1 family. This protein may be involved in leukemogenesis. Gene Aliases P13MTCP1, p8MTCP1 RefSeq Accession No. NC_000023.10, NG_005114.1, NT_167198.1 UniGene ID Not Available Ensembl Gene ID ENSG00000214827 Entrez Gene ID 4515 Assay Information Unique Assay ID qHsaCED0048630 Assay Type SYBR® Green Detected Coding Transcript(s) ENST00000369476, ENST00000362018, ENST00000596212, ENST00000597096 Amplicon Context Sequence TCCCCTGACCATTAAATGATGCTGTATCTGCCACAAGCGAGAGTTGTTATCCATG TAGCGCTCCTCCGGGTAGAGTTGCCACATGAGAGGTAGCTGGGAGGT Amplicon Length (bp) 72 Chromosome Location X:154293804-154293986 Assay Design Exonic Purification Desalted Validation Results Efficiency (%) 106 R2 0.9994 cDNA Cq 24.34 cDNA Tm (Celsius) 82 gDNA Cq 25.37 Page 1/5 PrimePCR™Assay Validation Report Specificity (%) 100 Information to assist with data interpretation is provided at the end of this report. Page 2/5 PrimePCR™Assay Validation Report MTCP1, Human Amplification Plot Amplification of cDNA generated from 25 ng of universal reference RNA Melt Peak Melt curve analysis of above amplification Standard
    [Show full text]
  • Structural Studies of the Complex Between Akt-In and the Akt2-PH Domain Suggest That the Peptide Acts As an Allosteric Inhibitor of the Akt Kinase
    The Open Spectroscopy Journal, 2009, 3, 65-76 65 Open Access Structural Studies of the Complex Between Akt-in and the Akt2-PH Domain Suggest that the Peptide Acts as an Allosteric Inhibitor of the Akt Kinase Virginie Ropars1,2,3, Philippe Barthe1,2,3, Chi-Shien Wang4, Wenlung Chen4, Der-Lii M. Tzou4,5, Anne Descours6, Loïc Martin6, Masayuki Noguchi7, Daniel Auguin1,2,3,,¶ and Christian Roumestand*,1,2,3 1CNRS UMR 5048, Centre de Biochimie Structurale, Montpellier, France 2INSERM U554, Montpellier, France 3Université Montpellier I et II, Montpellier, France 4Department of Applied Chemistry, National Chiayi University, Chiayi 60004, Taiwan, ROC 5Institute of Chemistry, Academia Sinica, Nankang, Taipei 11529, Taiwan, ROC 6CEA, iBiTecs, Service d’Ingénierie Moléculaire des Protéines, 91191 Gif sur Yvette, France 7Division of Cancer Biology, Institute for Genetic Medicine, Hokkaido University, N15 W7, Kita-ku, Sapporo 060-0815, Japan Abstract: Serine/threonine kinase Akt plays a central role in the regulation of cell survival and proliferation. Hence, the search for Akt specific inhibitors constitutes an attractive strategy for anticancer therapy. We have previously demonstrated that the proto-oncogene TCL1 coactivates Akt upon binding to its Plekstrin Homology Domain, and we proposed a model for the structure of the complex TCL1:Akt2-PHD. This model led to the rational design of Akt-in, a peptide inhibitor spanning the A ß-strand of human TCL1 that binds Akt2 PH domain and inhibits the kinase activation. In the present report, we used NMR spectroscopy to determine the 3D structure of the peptide free in solution and bound to Akt2-PHD.
    [Show full text]
  • Rat CLPS / Colipase Protein (His Tag)
    Rat CLPS / Colipase Protein (His Tag) Catalog Number: 80729-R08H General Information SDS-PAGE: Gene Name Synonym: CLPS Protein Construction: A DNA sequence encoding the rat Clps (NP_037271.1) (Met1-Gln112) was expressed with a polyhistidine tag at the C-terminus. Source: Rat Expression Host: HEK293 Cells QC Testing Purity: > 95 % as determined by SDS-PAGE. Endotoxin: Protein Description < 1.0 EU per μg protein as determined by the LAL method. Colipase belongs to the colipase family. Structural studies of the complex Stability: and of colipase alone have revealed the functionality of its architecture. It is a small protein with five conserved disulphide bonds. Structural analogies Samples are stable for up to twelve months from date of receipt at -70 ℃ have been recognised between a developmental protein, the pancreatic lipase C-terminal domain, the N-terminal domains of lipoxygenases and the Predicted N terminal: Ala 18 C-terminal domain of alpha-toxin. Colipase can only be detected in Molecular Mass: pancreatic acinar cells, suggesting regulation of expression by tissue- specific elements. Colipase allows lipase to anchor noncovalently to the The recombinant rat Clps consists 106 amino acids and predicts a surface of lipid micelles, counteracting the destabilizing influence of molecular mass of 11.9 kDa. intestinal bile salts. Without colipase the enzyme is washed off by bile salts, which have an inhibitory effect on the lipase. Colipase is a cofactor needed Formulation: by pancreatic lipase for efficient dietary lipid hydrolysis. It binds to the C- terminal, non-catalytic domain of lipase, thereby stabilising as active Lyophilized from sterile PBS, pH 7.4.
    [Show full text]
  • Biochemical Properties of Pancreatic Colipase from the Common Stingray
    Ben Bacha et al. Lipids in Health and Disease 2011, 10:69 http://www.lipidworld.com/content/10/1/69 RESEARCH Open Access Biochemical properties of pancreatic colipase from the common stingray Dasyatis pastinaca Abir Ben Bacha†, Aida Karray†, Lobna Daoud, Emna Bouchaala, Madiha Bou Ali, Youssef Gargouri and Yassine Ben Ali* Background: Pancreatic colipase is a required co-factor for pancreatic lipase, being necessary for its activity during hydrolysis of dietary triglycerides in the presence of bile salts. In the intestine, colipase is cleaved from a precursor molecule, procolipase, through the action of trypsin. This cleavage yields a peptide called enterostatin knoswn, being produced in equimolar proportions to colipase. Results: In this study, colipase from the common stingray Dasyatis pastinaca (CoSPL) was purified to homogeneity. The purified colipase is not glycosylated and has an apparent molecular mass of around 10 kDa. The NH2-terminal sequencing of purified CoSPL exhibits more than 55% identity with those of mammalian, bird or marine colipases. CoSPL was found to be less effective activator of bird and mammal pancreatic lipases than for the lipase from the same specie. The apparent dissociation constant (Kd) of the colipase/lipase complex and the apparent Vmax of the colipase-activated lipase values were deduced from the linear curves of the Scatchard plots. We concluded that Stingray Pancreatic Lipase (SPL) has higher ability to interact with colipase from the same species than with the mammal or bird ones. Conclusion: The fact that colipase is a universal lipase cofactor might thus be explained by a conservation of the colipase-lipase interaction site.
    [Show full text]
  • Association of Gene Ontology Categories with Decay Rate for Hepg2 Experiments These Tables Show Details for All Gene Ontology Categories
    Supplementary Table 1: Association of Gene Ontology Categories with Decay Rate for HepG2 Experiments These tables show details for all Gene Ontology categories. Inferences for manual classification scheme shown at the bottom. Those categories used in Figure 1A are highlighted in bold. Standard Deviations are shown in parentheses. P-values less than 1E-20 are indicated with a "0". Rate r (hour^-1) Half-life < 2hr. Decay % GO Number Category Name Probe Sets Group Non-Group Distribution p-value In-Group Non-Group Representation p-value GO:0006350 transcription 1523 0.221 (0.009) 0.127 (0.002) FASTER 0 13.1 (0.4) 4.5 (0.1) OVER 0 GO:0006351 transcription, DNA-dependent 1498 0.220 (0.009) 0.127 (0.002) FASTER 0 13.0 (0.4) 4.5 (0.1) OVER 0 GO:0006355 regulation of transcription, DNA-dependent 1163 0.230 (0.011) 0.128 (0.002) FASTER 5.00E-21 14.2 (0.5) 4.6 (0.1) OVER 0 GO:0006366 transcription from Pol II promoter 845 0.225 (0.012) 0.130 (0.002) FASTER 1.88E-14 13.0 (0.5) 4.8 (0.1) OVER 0 GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolism3004 0.173 (0.006) 0.127 (0.002) FASTER 1.28E-12 8.4 (0.2) 4.5 (0.1) OVER 0 GO:0006357 regulation of transcription from Pol II promoter 487 0.231 (0.016) 0.132 (0.002) FASTER 6.05E-10 13.5 (0.6) 4.9 (0.1) OVER 0 GO:0008283 cell proliferation 625 0.189 (0.014) 0.132 (0.002) FASTER 1.95E-05 10.1 (0.6) 5.0 (0.1) OVER 1.50E-20 GO:0006513 monoubiquitination 36 0.305 (0.049) 0.134 (0.002) FASTER 2.69E-04 25.4 (4.4) 5.1 (0.1) OVER 2.04E-06 GO:0007050 cell cycle arrest 57 0.311 (0.054) 0.133 (0.002)
    [Show full text]
  • Polymorphisms in PNLIP, Encoding Pancreatic Lipase, and Associations with Metabolic Traits
    J Hum Genet (2001) 46:320–324 © Jpn Soc Hum Genet and Springer-Verlag 2001 ORIGINAL ARTICLE Robert A. Hegele · D. Dan Ramdath · Matthew R. Ban Michael N. Carruthers · Christine V. Carrington Henian Cao Polymorphisms in PNLIP, encoding pancreatic lipase, and associations with metabolic traits Received: January 18, 2001 / Accepted: February 19, 2001 Abstract Pancreatic lipase (EC 3.1.1.3) is an exocrine se- Introduction cretion that hydrolyzes dietary triglycerides in the small intestine. We developed genomic amplification primers to sequence the 13 exons of PNLIP, which encodes pancreatic Pancreatic lipase (PL; EC 3.1.1.3), a 56-kD protein, is in- lipase, in order to screen for possible mutations in cell lines volved in the intestinal hydrolysis of dietary triglyceride to of four children with pancreatic lipase deficiency (OMIM fatty acids. PL deficiency (OMIM 246600) is associated with 246600). We found no missense or nonsense mutations in malabsorption of long-chain triglyceride fatty acids, failure these samples, but we found three silent single-nucleotide to thrive in infancy and childhood, and absence of PL secre- polymorphisms (SNPs), namely, 96A/C in exon 3, 486C/T in tion upon secretin stimulation (Sheldon 1964; Rey et al. exon 6, and 1359C/T in exon 13. In 50 normolipidemic 1966). PNLIP on chromosome 10q26.1 (Davis et al. 1991) is Caucasians, the PNLIP 96C and 486T alleles had frequen- a 13-exon gene that spans more than 20kb (Sims et al. 1993) cies of 0.083 and 0.150, respectively. The PNLIP 1359T and encodes the 465-amino acid PL mature protein (Lowe allele was absent from Caucasian, Chinese, South Asian, et al.
    [Show full text]
  • Regulation of the Akt Kinase by Interacting Proteins
    Oncogene (2005) 24, 7401–7409 & 2005 Nature Publishing Group All rights reserved 0950-9232/05 $30.00 www.nature.com/onc Regulation of the Akt kinase by interacting proteins Keyong Du1 and Philip N Tsichlis*,1 1Molecular Oncology Research Institute, Tufts-New England Medical Center, Boston, MA 02111, USA Ten years ago, it was observed that the Akt kinase revolutionized our understanding of cell function at is activated by phosphorylation via a phosphoinositide the molecular level.These technologies also allowed 3-kinase (PI-3K)-dependent process. This discovery gene- the identification of a large array of protein–protein rated enormous interest because it provided a link between interaction motifs that facilitate our understanding of PI-3K, an enzyme known to play a critical role in cellular signal transduction by providing clues on the potential physiology, and its downstream targets. Subsequently, it function of novel signaling proteins (Barnouin, 2004; was shown that the activity of the core components of the Miller and Stagljar, 2004). ‘PI-3K/Akt pathway’ is modulated by a complex network Akt1, also known as protein kinase Ba (PKBa) of regulatory proteins and pathways. Some of the Akt- (Bellacosa et al., 1991; Coffer and Woodgett, 1991; binding partners modulate its activation by external Jones et al., 1991), is the founding member of a protein signals by interacting with different domains of the Akt kinase family composed of three members, Akt1, Akt2, protein. This review focuses on the Akt interacting and Akt3.Akt family members regulate a diverse proteins and the mechanisms by which they regulate Akt array of cellular functions, including apoptosis, cellular activation.
    [Show full text]
  • Human CLPS / Colipase Protein (His Tag)
    Human CLPS / Colipase Protein (His Tag) Catalog Number: 13631-H08B General Information SDS-PAGE: Gene Name Synonym: CLPS Protein Construction: A DNA sequence encoding the human CLPS (P04118) (Met 1-Gln 112) was fused with a polyhistidine tag at the C-terminus. Source: Human Expression Host: Baculovirus-Insect Cells QC Testing Purity: > 90 % as determined by SDS-PAGE Endotoxin: Protein Description < 1.0 EU per μg of the protein as determined by the LAL method Colipase belongs to the colipase family. Structural studies of the complex Stability: and of colipase alone have revealed the functionality of its architecture. It is a small protein with five conserved disulphide bonds. Structural analogies ℃ Samples are stable for up to twelve months from date of receipt at -70 have been recognised between a developmental protein, the pancreatic lipase C-terminal domain, the N-terminal domains of lipoxygenases and the Ala 18 Predicted N terminal: C-terminal domain of alpha-toxin. Colipase can only be detected in Molecular Mass: pancreatic acinar cells, suggesting regulation of expression by tissue- specific elements. Colipase allows lipase to anchor noncovalently to the The recombinant human CLPS consists of 105 amino acids and predicts a surface of lipid micelles, counteracting the destabilizing influence of molecular mass of 11.5 kDa. It migrates as an approximately 12 KDa band in intestinal bile salts. Without colipase the enzyme is washed off by bile salts, SDS-PAGE under reducing conditions. which have an inhibitory effect on the lipase. Colipase is a cofactor needed by pancreatic lipase for efficient dietary lipid hydrolysis. It binds to the C- Formulation: terminal, non-catalytic domain of lipase, thereby stabilising as active conformation and considerably increasing the overall hydrophobic binding Lyophilized from sterile PBS, 500mM NaCl, pH 7.0, 10% gly site.
    [Show full text]
  • Tcl1 Enhances Akt Kinase Activity and Mediates Its Nuclear Translocation
    Tcl1 enhances Akt kinase activity and mediates its nuclear translocation Yuri Pekarsky*, Anatoliy Koval*, Cora Hallas*, Roberta Bichi*, Maria Tresini*, Scott Malstrom*, Giandomenico Russo†, Philip Tsichlis*, and Carlo M. Croce*‡ *Kimmel Cancer Center, Jefferson Medical College, Philadelphia, PA 19107; and †Istituto Dermopatico dell’Immacolata, Laboratory of Vascular Pathology, 00167 Rome, Italy Contributed by Carlo M. Croce, December 20, 1999 The TCL1 oncogene at 14q32.1 is involved in the development of wortmannin, a (PI-3K)-kinase inhibitor, completely inhibits the human mature T-cell leukemia. The mechanism of action of Tcl1 is activation of Akt (reviewed in ref. 9). Recent studies showed that unknown. Because the virus containing the v-akt oncogene causes Akt is a key player in the transduction of antiapoptotic and T-cell lymphoma in mice and Akt is a key player in transduction of proliferative signals in T-cells (refs. 10 and 11; reviewed in ref. antiapoptotic and proliferative signals in T-cells, we investigated 9). Activated Akt enhances both cell cycle progression and IL2 whether Akt and Tcl1 function in the same pathway. Coimmuno- production through the inhibition by phosphorylation of the precipitation experiments showed that endogenous Akt1 and Tcl1 proapoptotic factor Bad (11). Introduction of a constitutively physically interact in the T-cell leukemia cell line SupT11; both activated AKT1 transgene under the control of the proximal lck proteins also interact when cotransfected into 293 cells. Using promoter causes T-cell lymphomas in mice (S.M. and P.T., several AKT1 constructs in cotransfection experiments, we deter- unpublished data). In cultured cells, Akt1 can be localized in mined that this interaction occurs through the pleckstrin homology both the nucleus and cytoplasm (12).
    [Show full text]
  • NRF1) Coordinates Changes in the Transcriptional and Chromatin Landscape Affecting Development and Progression of Invasive Breast Cancer
    Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 11-7-2018 Decipher Mechanisms by which Nuclear Respiratory Factor One (NRF1) Coordinates Changes in the Transcriptional and Chromatin Landscape Affecting Development and Progression of Invasive Breast Cancer Jairo Ramos [email protected] Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Clinical Epidemiology Commons Recommended Citation Ramos, Jairo, "Decipher Mechanisms by which Nuclear Respiratory Factor One (NRF1) Coordinates Changes in the Transcriptional and Chromatin Landscape Affecting Development and Progression of Invasive Breast Cancer" (2018). FIU Electronic Theses and Dissertations. 3872. https://digitalcommons.fiu.edu/etd/3872 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida DECIPHER MECHANISMS BY WHICH NUCLEAR RESPIRATORY FACTOR ONE (NRF1) COORDINATES CHANGES IN THE TRANSCRIPTIONAL AND CHROMATIN LANDSCAPE AFFECTING DEVELOPMENT AND PROGRESSION OF INVASIVE BREAST CANCER A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in PUBLIC HEALTH by Jairo Ramos 2018 To: Dean Tomás R. Guilarte Robert Stempel College of Public Health and Social Work This dissertation, Written by Jairo Ramos, and entitled Decipher Mechanisms by Which Nuclear Respiratory Factor One (NRF1) Coordinates Changes in the Transcriptional and Chromatin Landscape Affecting Development and Progression of Invasive Breast Cancer, having been approved in respect to style and intellectual content, is referred to you for judgment.
    [Show full text]
  • The Human Gene Connectome As a Map of Short Cuts for Morbid Allele Discovery
    The human gene connectome as a map of short cuts for morbid allele discovery Yuval Itana,1, Shen-Ying Zhanga,b, Guillaume Vogta,b, Avinash Abhyankara, Melina Hermana, Patrick Nitschkec, Dror Friedd, Lluis Quintana-Murcie, Laurent Abela,b, and Jean-Laurent Casanovaa,b,f aSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065; bLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Paris Descartes University, Institut National de la Santé et de la Recherche Médicale U980, Necker Medical School, 75015 Paris, France; cPlateforme Bioinformatique, Université Paris Descartes, 75116 Paris, France; dDepartment of Computer Science, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel; eUnit of Human Evolutionary Genetics, Centre National de la Recherche Scientifique, Unité de Recherche Associée 3012, Institut Pasteur, F-75015 Paris, France; and fPediatric Immunology-Hematology Unit, Necker Hospital for Sick Children, 75015 Paris, France Edited* by Bruce Beutler, University of Texas Southwestern Medical Center, Dallas, TX, and approved February 15, 2013 (received for review October 19, 2012) High-throughput genomic data reveal thousands of gene variants to detect a single mutated gene, with the other polymorphic genes per patient, and it is often difficult to determine which of these being of less interest. This goes some way to explaining why, variants underlies disease in a given individual. However, at the despite the abundance of NGS data, the discovery of disease- population level, there may be some degree of phenotypic homo- causing alleles from such data remains somewhat limited. geneity, with alterations of specific physiological pathways under- We developed the human gene connectome (HGC) to over- come this problem.
    [Show full text]
  • Uniprot Acceprotiens 121 113 Ratio(113/12 114 Ratio
    Uniprot Acceprotiens 121 113 ratio(113/12 114 ratio(114/12 115 ratio(115/12 116 ratio(116/12 117 ratio(117/12 118 ratio(118/12 119 ratio(119/121) P02768 Serum albumin OS=Homo s666397.2 862466.6 1.29 593482.1 0.89 2220420.5 3.33 846469.3 1.27 634302.5 0.95 736961.1 1.11 842297.5 1.26 P02760 Protein AMBP OS=Homo s381627.7 294812.3 0.77 474165.8 1.24 203377.3 0.53 349197.6 0.92 346271.7 0.91 328356.1 0.86 411229.3 1.08 B4E1B2 cDNA FLJ53691, highly sim78511.8 107560.1 1.37 85218.8 1.09 199640.4 2.54 90022.3 1.15 73427.3 0.94 82722 1.05 102491.8 1.31 A0A0K0K1HEpididymis secretory sperm 3358.1 4584.8 1.37 4234.8 1.26 8496.1 2.53 4193.7 1.25 3507.1 1.04 3632.2 1.08 4873.3 1.45 D3DNU8 Kininogen 1, isoform CRA_302648.3 294936.6 0.97 257956.9 0.85 193831.3 0.64 290406.7 0.96 313453.3 1.04 279805.5 0.92 228883.9 0.76 B4E1C2 Kininogen 1, isoform CRA_167.9 229.7 1.37 263.2 1.57 278 1.66 326 1.94 265.5 1.58 290.3 1.73 341.5 2.03 O60494 Cubilin OS=Homo sapiens G40132.6 45037.5 1.12 38654.5 0.96 34055.8 0.85 39708.6 0.99 44702.9 1.11 45025.7 1.12 32701.3 0.81 P98164 Low-density lipoprotein rece40915.4 45344.8 1.11 35817.7 0.88 35721.8 0.87 42157.7 1.03 46693.4 1.14 48624 1.19 38847.7 0.95 A0A024RABHeparan sulfate proteoglyca46985.3 43536.1 0.93 49827.7 1.06 33964.3 0.72 44780.9 0.95 46858.6 1.00 47703.5 1.02 37785.7 0.80 P01133 Pro-epidermal growth factor 75270.8 73109.5 0.97 66336.1 0.88 56680.9 0.75 70877.8 0.94 76444.3 1.02 81110.3 1.08 65749.7 0.87 Q6N093 Putative uncharacterized pro47825.3 55632.5 1.16 48428.3 1.01 63601.5 1.33 65204.2 1.36 59384.5
    [Show full text]